Atluri Cardiovascular Research Lab
Our lab focuses on developing novel therapeutics for both acute and chronic heart failure. Using molecular and tissue engineering approaches that harness the power of myocardial regeneration, neovascularizaton, and optimization of myocyte function we address the problem of heart failure. Analysis is performed in both in both small and large animal models with the ultimate focus of rapid clinical translation of therapeutic strategies. We have worked with novel biomaterials to optimize therapeutic efficiency and provide minimally invasive delivery options.
Clinical investigation is focused on optimization of heart transplant, mechanical circulatory support, and minimally invasive and robotic cardiac surgical procedures.
Research News at Penn
Research at Penn 2 weeks ago
Research at Penn 2 weeks, 1 day ago
Research at Penn 4 weeks ago
Atluri Lab Events
Heart Valve Society 6th Annual Meeting
Feb. 15-16, 2020, Abu Dhabi, United Arab Emirates
Dr. Mark Helmers, a PGY4 Integrated Cardiac Surgery Resident in our lab, will be presenting his research on comparing the surgical outcomes of minimally invasive surgery compared to full-sternotomy for patients with pulmonary hypertension.
International Society of Heart and Lung Transplantation 40th Anniversary Meeting and Scientific Sessions
April 22-24, 2020, Montreal, Canada
Dr. Peter Altshuler, a PGY4 General Surgery Resident in our lab, will be presenting his work on cardiac transplant outcomes in the upcoming ISHLT 2020 meeting. His abstracts, entitled “HCV Seropositive Donors Positively Impact Heart Transplant Rates and Waitlist Mortality without Compromising Outcomes”, and “Use of Extended-Donor Criteria Hearts in Amyloidosis Patients Demonstrates Similar Morbidity and Mortality Compared to Non-Amyloid Recipients” explore outcomes in high-risk transplant candidates and marginal donor populations.